Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of age on plasma propranolol levels.

Literature DB >> 7426279

Effect of age on plasma propranolol levels.

R E Schneider, H Bishop, R A Yates, C P Quarterman, M J Kendall.

Abstract

Entities: Chemical

Mesh：

Substances：
Propranolol

Year: 1980 PMID： 7426279 PMCID： PMC1430031 DOI： 10.1111/j.1365-2125.1980.tb01736.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

7 in total

1. Effects of inflammatory disease on plasma oxprenolol concentrations.

Authors: M J Kendall; C P Quarterman; H Bishop; R E Schneider
Journal: Br Med J Date: 1979-08-25

2. Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease.

Authors: R E Schneider; J Babb; H Bishop; M Mitchard; A M Hoare
Journal: Br Med J Date: 1976-10-02

3. Effects of age and cigarette smoking on propranolol disposition.

Authors: R E Vestal; A J Wood; R A Branch; D G Shand; G R Wilkinson
Journal: Clin Pharmacol Ther Date: 1979-07 Impact factor: 6.875

4. The effect of ageing on the hepatic clearance of propranolol.

Authors: C M Castleden; C F George
Journal: Br J Clin Pharmacol Date: 1979-01 Impact factor: 4.335

5. The effect of age on plasma levels of propranolol and practolol in man.

Authors: C M Castleden; C M Kaye; R L Parsons
Journal: Br J Clin Pharmacol Date: 1975-08 Impact factor: 4.335

6. Absorption of propranolol and practolol in Coeliac disease.

Authors: R L Parsons; C M Kaye; K Raymond; J R Trounce; P Turner
Journal: Gut Date: 1976-02 Impact factor: 23.059

7. Plasma propranolol concentrations and the erythrocyte sedimentation rate.

Authors: R E Schneider; H Bishop; C F Hawkins
Journal: Br J Clin Pharmacol Date: 1979-07 Impact factor: 4.335

7 in total

18 in total

Review 1. Required beta blocker profile in the elderly.

Authors: L H Opie
Journal: Cardiovasc Drugs Ther Date: 1991-01 Impact factor: 3.727

2. The treatment of hypertension in the elderly.

Authors: M Chellingsworth; D G Beevers
Journal: Postgrad Med J Date: 1986-01 Impact factor: 2.401

3. Pharmacokinetics of pirprofen and its pyrrol metabolite in elderly patients.

Authors: F A Rossi; M Ferrero; G E Balladore; L Zecca; F Fraschini; P Ferrario; E Bichisao; G C Monza; V Maresca
Journal: Eur J Clin Pharmacol Date: 1988 Impact factor: 2.953

4. Systolic functional response of normal older and younger adult left ventricles to beta-blockade during exercise.

Authors: Z S Kyriakides; G Papaioannou; I A Paraskevaidis; T M Kolettis; D T Kremastinos
Journal: Cardiovasc Drugs Ther Date: 1995-04 Impact factor: 3.727

5. Pharmacokinetics of metoprolol in healthy, elderly, non-smoking individuals after a single dose and two weeks of treatment.

Authors: M Larsson; S Landahl; P Lundborg; C G Regårdh
Journal: Eur J Clin Pharmacol Date: 1984 Impact factor: 2.953

6. Pharmacokinetics of metoprolol and its metabolite alpha-OH-metoprolol in healthy, non-smoking, elderly individuals.

Authors: C G Regårdh; S Landahl; M Larsson; P Lundborg; B Steen; K J Hoffmann; P O Lagerström
Journal: Eur J Clin Pharmacol Date: 1983 Impact factor: 2.953

7. A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.

Authors: J W Rigby; A K Scott; G M Hawksworth; J C Petrie
Journal: Br J Clin Pharmacol Date: 1985-10 Impact factor: 4.335